Industry comments were recently made public on the U.S. Nuclear Regulatory Commission’s (NRC’s) draft “Vision and Strategy” statement (draft vision statement) for non-light water reactors, a.k.a. advanced reactors. This effort represents the NRC’s most significant attempt in recent years to pave the way forward for advanced reactors.
The National Institutes of Health (NIH) and Food and Drug Administration (FDA) announced on March 17, 2016, their co-development of a draft clinical trial protocol template for use by NIH-funded investigators. The template is meant for use in writing phase 2 or 3 clinical trial protocols where Investigational New Drug application (IND) or Investigational Device